What does CUSIP 15117B202 represent in this 13F holders report?

CUSIP 15117B202 is the security identifier for CLDX - CELLDEX THERAPEUTICS INC - COMMON STOCK used to aggregate holder disclosures.

How many institutions held CLDX - CELLDEX THERAPEUTICS INC - COMMON STOCK in Q4 2020?

120 institutional investors reported CLDX - CELLDEX THERAPEUTICS INC - COMMON STOCK for Q4 2020. Use the holders table for investor-level position and value details.

CELLDEX THERAPEUTICS INC - COMMON STOCK (CLDX)

CUSIP: 15117B202

Q4 2020 13F Holders as of 31 Dec 2020

Type / Class: Equity / COMMON STOCK
Shares outstanding: 66,765,905
Total 13F shares: 36,816,222
Share change: +3,094,046
Total reported value: $645,045,236
Put/Call ratio: 69%
Price per share: $17.52
Number of holders: 120
Value change: +$72,177,637
Number of buys: 73
Number of sells: 37

Quarterly Holders Quick Answers

What is CUSIP 15117B202?
CUSIP 15117B202 identifies CLDX - CELLDEX THERAPEUTICS INC - COMMON STOCK in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2021
Previous quarter: Q3 2020

Recent filing periods for CUSIP 15117B202:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of CLDX - CELLDEX THERAPEUTICS INC - COMMON STOCK (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
RTW INVESTMENTS, LP	13F	Company	4.7%	3,120,137	$46,272,000	—	30 Sep 2020	13F
BVF INC/IL	13F	Company	4.6%	3,066,797	$45,481,000	—	30 Sep 2020	13F
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F	Company	3.1%	2,050,000	$30,402,000	—	30 Sep 2020	13F
Redmile Group, LLC	13F	Company	3%	1,989,200	$29,500,000	—	30 Sep 2020	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	2.6%	1,736,675	$25,755,000	—	30 Sep 2020	13F
VANGUARD GROUP INC	13F	Company	2.6%	1,723,317	$25,557,000	—	30 Sep 2020	13F
Vivo Capital, LLC	13F	Company	2.6%	1,722,500	$25,545,000	—	30 Sep 2020	13F
ACUTA CAPITAL PARTNERS, LLC	13F	Company	2.3%	1,545,000	$22,912,000	—	30 Sep 2020	13F
Ikarian Capital, LLC	13F	Company	2.2%	1,469,730	$21,796,000	—	30 Sep 2020	13F
Polar Capital LLP	13F	Company	1.9%	1,250,000	$18,538,000	—	30 Sep 2020	13F
Logos Global Management LP	13F	Company	1.8%	1,200,000	$17,796,000	—	30 Sep 2020	13F
Boxer Capital, LLC	13F	Company	1.5%	1,000,000	$14,830,000	—	30 Sep 2020	13F
Opaleye Management Inc.	13F	Company	1.5%	992,000	$14,711,000	—	30 Sep 2020	13F
VR Adviser, LLC	13F	Company	1.2%	800,000	$11,864,000	—	30 Sep 2020	13F
BlackRock Finance, Inc.	13F	Company	1.2%	791,573	$11,739,000	—	30 Sep 2020	13F
ORBIMED ADVISORS LLC	13F	Company	0.94%	625,000	$9,269,000	—	30 Sep 2020	13F
Invesco Ltd.	13F	Company	0.8%	534,584	$7,928,000	—	30 Sep 2020	13F
EVENTIDE ASSET MANAGEMENT, LLC	13F	Company	0.76%	506,179	$7,507,000	—	30 Sep 2020	13F
Cresset Asset Management, LLC	13F	Company	0.69%	457,666	$6,787,000	—	30 Sep 2020	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.66%	443,356	$6,575,000	—	30 Sep 2020	13F
DRIEHAUS CAPITAL MANAGEMENT LLC	13F	Company	0.6%	401,763	$5,958,000	—	30 Sep 2020	13F
DEUTSCHE BANK AG\	13F	Company	0.59%	394,273	$5,847,000	—	30 Sep 2020	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.58%	389,942	$5,783,000	—	30 Sep 2020	13F
SPHERA FUNDS MANAGEMENT LTD.	13F	Company	0.55%	370,000	$5,487,000	—	30 Sep 2020	13F
RA CAPITAL MANAGEMENT, L.P.	13F	Company	0.53%	353,072	$5,236,000	—	30 Sep 2020	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.46%	308,193	$4,571,000	—	30 Sep 2020	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.39%	257,629	$3,820,000	—	30 Sep 2020	13F
Marshall Wace North America L.P.	13F	Company	0.38%	254,723	$3,778,000	—	30 Sep 2020	13F
BOOTHBAY FUND MANAGEMENT, LLC	13F	Company	0.28%	186,117	$2,760,000	—	30 Sep 2020	13F
Verition Fund Management LLC	13F	Company	0.25%	167,624	$2,486,000	—	30 Sep 2020	13F
Eversept Partners, LP	13F	Company	0.23%	150,494	$2,231,826	—	30 Sep 2020	13F
PURA VIDA INVESTMENTS, LLC	13F	Company	0.22%	144,200	$2,138,000	—	30 Sep 2020	13F
Informed Momentum Co LLC	13F	Company	0.21%	141,129	$2,093,000	—	30 Sep 2020	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.15%	103,257	$1,531,000	—	30 Sep 2020	13F
Global IMC LLC	13F	Company	0.15%	98,750	$1,464,000	—	30 Sep 2020	13F
NORTHERN TRUST CORP	13F	Company	0.13%	88,345	$1,311,000	—	30 Sep 2020	13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	13F	Company	0.12%	80,026	$1,187,000	—	30 Sep 2020	13F
J. Goldman & Co LP	13F	Company	0.11%	76,055	$1,128,000	—	30 Sep 2020	13F
Qube Research & Technologies Ltd	13F	Company	0.11%	73,584	$1,091,000	—	30 Sep 2020	13F
Connor, Clark & Lunn Investment Management Ltd.	13F	Company	0.08%	51,579	$765,000	—	30 Sep 2020	13F
HUSSMAN STRATEGIC ADVISORS, INC.	13F	Company	0.08%	51,000	$756,000	—	30 Sep 2020	13F
PERCEPTIVE ADVISORS LLC	13F	Company	0.07%	49,751	$738,000	—	30 Sep 2020	13F
Altshuler Shaham Ltd	13F	Company	0.07%	46,500	$690,000	—	30 Sep 2020	13F
ALGERT GLOBAL LLC	13F	Company	0.07%	45,070	$668,000	—	30 Sep 2020	13F
HighVista Strategies LLC	13F	Company	0.07%	44,829	$665,000	—	30 Sep 2020	13F
MIRABELLA FINANCIAL SERVICES LLP	13F	Company	0.05%	36,087	$535,000	—	30 Sep 2020	13F
Creative Planning	13F	Company	0.05%	35,347	$524,000	—	30 Sep 2020	13F
Squarepoint Ops LLC	13F	Company	0.05%	33,382	$495,000	—	30 Sep 2020	13F
Mirador Capital Partners LP	13F	Company	0.04%	25,466	$378,000	—	30 Sep 2020	13F
STATE STREET CORP	13F	Company	0.04%	25,387	$376,000	—	30 Sep 2020	13F

Institutional Holders of CELLDEX THERAPEUTICS INC - COMMON STOCK (CLDX) as of Q4 2020

As of 31 Dec 2020, CELLDEX THERAPEUTICS INC - COMMON STOCK (CLDX) was held by 120 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 36,816,222 shares. The largest 10 holders included RTW INVESTMENTS, LP, Redmile Group, LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., EVENTIDE ASSET MANAGEMENT, LLC, STATE STREET CORP, VANGUARD GROUP INC, Acuta Capital Partners, LLC, CITADEL ADVISORS LLC, Ikarian Capital, LLC, and Vivo Capital, LLC. This page lists 120 institutional shareholders reporting positions in this security for the Q4 2020 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q4 2020 vs Q3 2020 Across Filers

Q3 2020 holders

Q4 2020 holders

120

Holder diff

Investor	Q3 2020 Shares	Q4 2020 Shares	Share Diff	Share Chg %	Q3 2020 Value $	Q4 2020 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.